Sponsor content

Regenerative cartilage therapy targets EU launch

co.don AG currently markets its regenerative therapy methods in Germany, where uptake is increasing among orthopedic surgeons, trauma surgeons and neurosurgeons.

Go to the profile of co.don
Sep 06, 2016
1
0
Like 1 Comment
Page of
Go to the profile of co.don

co.don

co.don AG, a fully integrated biopharmaceutical company, is a leading specialist in autologous cell cultivation (i.e., using the patient’s own cells) for the regenerative treatment of articular cartilage defects and spinal disc defects.

No comments yet.